BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.376,73 PKT -7,97 PKT -0,58 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
31.08.17 UBS Neutral BNP PARIBAS
31.08.17 UBS Outperform BNP PARIBAS
30.08.17 Zurich Insurance Neutral JP Morgan Chase & Co.
30.08.17 Swiss Re Equal weight Barclays Capital
29.08.17 Novartis Neutral JP Morgan Chase & Co.
29.08.17 Swiss Re buy Deutsche Bank AG
28.08.17 Swiss Re buy Deutsche Bank AG
28.08.17 Novartis Neutral UBS AG
28.08.17 Novartis buy Kepler Cheuvreux
28.08.17 Swiss Re Underperform BNP PARIBAS
24.08.17 Roche Conviction Buy List Goldman Sachs Group Inc.
21.08.17 Holcim Hold Deutsche Bank AG
16.08.17 Zurich Insurance Underperform Macquarie Research
16.08.17 Swiss Re overweight Morgan Stanley
15.08.17 Swiss Re Verkaufen Norddeutsche Landesbank (Nord/LB)
15.08.17 UBS buy HSBC
15.08.17 Roche buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
14.08.17 Zurich Insurance Neutral UBS AG
14.08.17 Swiss Re Sell UBS AG
14.08.17 Zurich Insurance Hold Kepler Cheuvreux
14.08.17 Swiss Re Reduce Commerzbank AG
14.08.17 Zurich Insurance Outperform Credit Suisse Group
11.08.17 Zurich Insurance kaufen DZ BANK
11.08.17 Holcim Neutral UBS AG
11.08.17 Zurich Insurance Neutral JP Morgan Chase & Co.
11.08.17 Zurich Insurance Conviction Buy Goldman Sachs Group Inc.
11.08.17 UBS buy HSBC
11.08.17 Givaudan Underweight Barclays Capital
11.08.17 UBS buy HSBC
11.08.17 UBS buy Goldman Sachs Group Inc.
10.08.17 Zurich Insurance Hold S&P Capital IQ
10.08.17 Zurich Insurance Neutral UBS AG
10.08.17 UBS buy Citigroup Corp.
10.08.17 UBS buy Citigroup Corp.
09.08.17 Swiss Re overweight JP Morgan Chase & Co.
08.08.17 Nestlé overweight JP Morgan Chase & Co.
08.08.17 Givaudan overweight JP Morgan Chase & Co.
08.08.17 Holcim Neutral JP Morgan Chase & Co.
08.08.17 Holcim buy Citigroup Corp.
08.08.17 Roche Conviction Buy List Goldman Sachs Group Inc.